Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia

NCT06718062 is registered in ClinicalTrials.gov with Hansung University as lead sponsor.

NCT NCT06718062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06718062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia
Lead sponsor
Hansung University
Phase
Phase 4
Overall status
Completed
Start date
May 1, 2021
Completion date
October 1, 2024
Enrollment
66 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension,essential, hyperuricemia